VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.5668
0.00 (0.00%)
At close: Jan 16, 2026, 4:00 PM EST
0.5600
-0.0068 (-1.20%)
Pre-market: Jan 20, 2026, 7:30 AM EST
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $18.87 million as of January 20, 2026. Its market cap has decreased by -61.82% in one year.
Market Cap
18.87M
Enterprise Value
-13.83M
1-Year Change
-61.82%
Ranking
Category
Stock Price
$0.57
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $18.87M, a decrease of -91.79%. That is a compound annual growth rate of -34.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 18.87M | -2.29% |
| Dec 31, 2025 | 19.31M | -60.93% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |